Quintiles And Indonesia’s Prodia Sign Pact For Global Trials With First Trial Initiated In Diabetes
This article was originally published in PharmAsia News
Executive Summary
A deal between Quintiles and Jakarta-based Prodia breaks a regulatory logjam that had led to a sharp decrease in clinical trials in Indonesia